Respiratory rate (RR) is typically the first vital sign to change when a patient decompensates. Despite this, RR is often monitored infrequently and inaccurately. The Circadia Contactless Breathing Monitor™ (model C100) is a novel device that uses ultra-wideband radar to monitor RR continuously and un-obtrusively. Performance of the Circadia Monitor was assessed by direct comparison to manually scored reference data. Data were collected across a range of clinical and non-clinical settings, considering a broad range of user characteristics and use cases, in a total of 50 subjects. Bland–Altman analysis showed high agreement with the gold standard reference for all study data, and agreement fell within the predefined acceptance criteria of ±5 breaths per minute (BrPM). The 95% limits of agreement were −3.0 to 1.3 BrPM for a nonprobability sample of subjects while awake, −2.3 to 1.7 BrPM for a clinical sample of subjects while asleep, and −1.2 to 0.7 BrPM for a sample of healthy subjects while asleep. Accuracy rate, using an error margin of ±2 BrPM, was found to be 90% or higher. Results demonstrate that the Circadia Monitor can effectively and efficiently be used for accurate spot measurements and continuous bedside monitoring of RR in low acuity settings, such as the nursing home or hospital ward, or for remote patient monitoring.

Although polysomnography (PSG) remains the gold standard for studying sleep in the lab, the development of wearable and 'nearable' non-EEG based sleep monitors has the potential to make long-term sleep monitoring in a home environment possible. However, validation of these novel technologies against PSG is required. The current study aims to evaluate the sleep staging performance of the radar-based Circadia Contactless Breathing Monitor (model C100) and proprietary Sleep Analysis Algorithm, both in a home and sleep lab environment, on cohorts of healthy sleepers. The C100 device was initially used to record 17 nights of sleep data from 9 participants alongside PSG, with a subsequent 24 nights of PSG data for validation purposes. Respiration and body movement features were extracted from sensor data, and a machine learning algorithm was developed to perform sleep stage prediction. The algorithm was trained using PSG data obtained in the initial dataset (n=17), and validated using leaveone-subject-out cross-validation. An epoch-by-epoch recall (true positive rate) of 75.0 %, 59.9 %, 74.8 % and 57.1 %, was found for 'Deep', 'Light', 'REM' and 'Wake' respectively. Highly similar results were obtained in the independent validation dataset (n=24), indicating robustness of results and generalizability of the sleep staging model, at least in the healthy population. The device was found to outperform both a consumer and medical grade wrist-worn monitoring device (Fitbit Alta HR and Philips Respironics Actiwatch) on sleep metric estimation accuracy. These results indicate that the developed non-contact monitor forms a viable alternative to existing clinically used wrist-worn methods, and that longitudinal monitoring of sleep stages in a home environment becomes feasible.